PL3087989T3 - Preparaty stałe zawierające tofogliflozynę i sposób ich wytwarzania - Google Patents
Preparaty stałe zawierające tofogliflozynę i sposób ich wytwarzaniaInfo
- Publication number
- PL3087989T3 PL3087989T3 PL14874030T PL14874030T PL3087989T3 PL 3087989 T3 PL3087989 T3 PL 3087989T3 PL 14874030 T PL14874030 T PL 14874030T PL 14874030 T PL14874030 T PL 14874030T PL 3087989 T3 PL3087989 T3 PL 3087989T3
- Authority
- PL
- Poland
- Prior art keywords
- tofogliflozin
- producing
- same
- solid preparations
- preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013273060 | 2013-12-27 | ||
PCT/JP2014/084561 WO2015099139A1 (ja) | 2013-12-27 | 2014-12-26 | トホグリフロジンを含有する固形製剤及びその製造方法 |
EP14874030.1A EP3087989B1 (en) | 2013-12-27 | 2014-12-26 | Solid preparations comprising tofogliflozin and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3087989T3 true PL3087989T3 (pl) | 2019-07-31 |
Family
ID=53478978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14874030T PL3087989T3 (pl) | 2013-12-27 | 2014-12-26 | Preparaty stałe zawierające tofogliflozynę i sposób ich wytwarzania |
Country Status (22)
Country | Link |
---|---|
US (2) | US10231930B2 (pl) |
EP (2) | EP3482748A1 (pl) |
JP (5) | JP6513030B2 (pl) |
KR (2) | KR20210082557A (pl) |
CN (2) | CN105828826B (pl) |
AU (1) | AU2014370847B2 (pl) |
BR (1) | BR112016013164B1 (pl) |
CA (1) | CA2934832C (pl) |
DK (1) | DK3087989T3 (pl) |
ES (1) | ES2704065T3 (pl) |
HK (1) | HK1224221A1 (pl) |
HR (1) | HRP20182199T1 (pl) |
HU (1) | HUE041983T2 (pl) |
LT (1) | LT3087989T (pl) |
MX (2) | MX370342B (pl) |
PL (1) | PL3087989T3 (pl) |
PT (1) | PT3087989T (pl) |
RU (1) | RU2700164C2 (pl) |
SI (1) | SI3087989T1 (pl) |
TR (1) | TR201821042T4 (pl) |
TW (2) | TWI715523B (pl) |
WO (1) | WO2015099139A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2674428T1 (sl) | 2006-04-07 | 2016-07-29 | Vertex Pharmaceuticals Incorporated | Modulatorji transporterjev atp-vezavne kasete |
AU2014370847B2 (en) * | 2013-12-27 | 2020-02-20 | Chugai Seiyaku Kabushiki Kaisha | Solid preparations containing tofogliflozin and process of producing the same |
CN108640958B (zh) * | 2017-05-05 | 2021-03-30 | 镇江圣安医药有限公司 | 异苯并呋喃衍生物、其药物组合物和制剂以及用途 |
CN107811983A (zh) * | 2017-12-04 | 2018-03-20 | 威海贯标信息科技有限公司 | 一种托格列净组合物 |
CN107759649A (zh) * | 2017-12-12 | 2018-03-06 | 威海贯标信息科技有限公司 | 一种托格列净新晶型 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56145214A (en) | 1980-04-11 | 1981-11-11 | Taiho Yakuhin Kogyo Kk | Ubidecarenone tablet |
JP2626975B2 (ja) | 1987-03-30 | 1997-07-02 | エーザイ株式会社 | 低融点油性物質含有錠剤 |
ES2082723B1 (es) | 1994-07-20 | 1996-10-01 | Lilly Sa | Formulacion farmaceutica de fluoxetina en forma dispersable. |
JPH10287561A (ja) | 1997-04-11 | 1998-10-27 | Taisho Pharmaceut Co Ltd | イブプロフェン配合固形製剤及びその製造方法 |
JP2000239185A (ja) | 1999-02-16 | 2000-09-05 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
CA2524827A1 (en) | 2003-05-06 | 2004-11-25 | Nirmal Mulye | Controlled release formulation of erythromycin derivatives |
JP2005104934A (ja) | 2003-10-01 | 2005-04-21 | Eisai Co Ltd | 新規組成物及びその製造方法 |
JP4997741B2 (ja) | 2004-11-12 | 2012-08-08 | 大正製薬株式会社 | 低融点薬物含有粉粒体及びその製造方法 |
TW200637869A (en) * | 2005-01-28 | 2006-11-01 | Chugai Pharmaceutical Co Ltd | The spiroketal derivatives and the use as therapeutical agent for diabetes of the same |
PE20090185A1 (es) * | 2007-03-22 | 2009-02-28 | Bristol Myers Squibb Co | Formulaciones farmaceuticas que contienen un inhibidor sglt2 |
JP4072195B2 (ja) | 2007-10-18 | 2008-04-09 | キッセイ薬品工業株式会社 | 速放性経口医薬組成物 |
TW201011043A (en) * | 2008-06-20 | 2010-03-16 | Chugai Pharmaceutical Co Ltd | Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives |
NZ594024A (en) * | 2009-02-13 | 2013-08-30 | Boehringer Ingelheim Int | Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient |
US20130035281A1 (en) * | 2011-02-09 | 2013-02-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
WO2012115249A1 (ja) | 2011-02-25 | 2012-08-30 | 中外製薬株式会社 | スピロケタール誘導体の結晶 |
AU2012264736A1 (en) | 2011-06-03 | 2013-11-28 | Boehringer Ingelheim International Gmbh | SGLT-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents |
PT2981269T (pt) | 2013-04-04 | 2023-10-10 | Boehringer Ingelheim Vetmedica Gmbh | Tratamento de distúrbios metabólicos em animais equinos |
AU2014370847B2 (en) * | 2013-12-27 | 2020-02-20 | Chugai Seiyaku Kabushiki Kaisha | Solid preparations containing tofogliflozin and process of producing the same |
-
2014
- 2014-12-26 AU AU2014370847A patent/AU2014370847B2/en active Active
- 2014-12-26 CN CN201480070348.6A patent/CN105828826B/zh active Active
- 2014-12-26 JP JP2015555053A patent/JP6513030B2/ja active Active
- 2014-12-26 MX MX2016008527A patent/MX370342B/es active IP Right Grant
- 2014-12-26 CN CN202110319378.8A patent/CN113058038B/zh active Active
- 2014-12-26 PL PL14874030T patent/PL3087989T3/pl unknown
- 2014-12-26 US US15/108,335 patent/US10231930B2/en active Active
- 2014-12-26 TW TW103145815A patent/TWI715523B/zh active
- 2014-12-26 HU HUE14874030A patent/HUE041983T2/hu unknown
- 2014-12-26 TR TR2018/21042T patent/TR201821042T4/tr unknown
- 2014-12-26 DK DK14874030.1T patent/DK3087989T3/en active
- 2014-12-26 LT LTEP14874030.1T patent/LT3087989T/lt unknown
- 2014-12-26 CA CA2934832A patent/CA2934832C/en active Active
- 2014-12-26 PT PT14874030T patent/PT3087989T/pt unknown
- 2014-12-26 SI SI201431027T patent/SI3087989T1/sl unknown
- 2014-12-26 EP EP18213096.3A patent/EP3482748A1/en not_active Withdrawn
- 2014-12-26 WO PCT/JP2014/084561 patent/WO2015099139A1/ja active Application Filing
- 2014-12-26 KR KR1020217019961A patent/KR20210082557A/ko not_active Application Discontinuation
- 2014-12-26 EP EP14874030.1A patent/EP3087989B1/en active Active
- 2014-12-26 KR KR1020167020083A patent/KR102395687B1/ko active IP Right Grant
- 2014-12-26 BR BR112016013164-9A patent/BR112016013164B1/pt active IP Right Grant
- 2014-12-26 ES ES14874030T patent/ES2704065T3/es active Active
- 2014-12-26 TW TW109144442A patent/TWI774159B/zh active
- 2014-12-26 RU RU2016130602A patent/RU2700164C2/ru active
-
2016
- 2016-06-24 MX MX2019008865A patent/MX2019008865A/es unknown
- 2016-11-03 HK HK16112651.7A patent/HK1224221A1/zh unknown
-
2018
- 2018-12-31 HR HRP20182199TT patent/HRP20182199T1/hr unknown
-
2019
- 2019-01-29 US US16/260,530 patent/US10398653B2/en active Active
- 2019-02-22 JP JP2019030773A patent/JP6759390B2/ja active Active
-
2020
- 2020-09-02 JP JP2020147286A patent/JP2020203918A/ja active Pending
-
2022
- 2022-06-01 JP JP2022089651A patent/JP2022116267A/ja active Pending
-
2024
- 2024-02-29 JP JP2024030315A patent/JP2024063140A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1206755A1 (en) | Low acidic species compositions and methods for producing and using the same | |
SG10201407632UA (en) | Transducer and method for forming the same | |
ZA201507161B (en) | Dental devices and systems and methods for making the same | |
PT3065845T (pt) | Sistema de filtragem e método para operar um sistema de filtragem | |
EP3006415B8 (en) | Method for producing nanocement and nanocement | |
EP3008170A4 (en) | SC-CELLS AND COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
ZA201604328B (en) | 1,2-naphthoquinone derivative and method for preparing same | |
EP2949783A4 (en) | LUBICLE ELEMENT AND METHOD FOR THE PRODUCTION THEREOF | |
IL240665A0 (en) | Improved aluminum-magnesium-lithium alloys and methods for their production | |
HRP20182199T1 (hr) | Kruti pripravci koji sadrže tofogliflozin i postupak za njihovu proizvodnju | |
GB201406038D0 (en) | Autotroph-based deodorizer and method for manufacturing the same | |
EP3089951A4 (en) | Ceramic and method for preparing the same | |
EP3057435A4 (en) | Structured triacylglycerols and methods for making the same | |
IL240423B (en) | Arrangement for a filter and method for its use | |
ZA201509017B (en) | Pcd elements and process for making the same | |
EP3021772A4 (en) | Spinal construct and method | |
ZA201602129B (en) | Audiometry system and method | |
SG11201701354VA (en) | Oligosaccharide preparation and method for producing the same | |
PL3091005T3 (pl) | Pochodna 1,2-naftochinonu i sposób jej wytwarzania | |
EP2756766B8 (en) | Brine and method for the manufacture thereof | |
HK1204129A1 (en) | Cashier system and method for operating the cashier system | |
IL246199A0 (en) | Tampon and method for its preparation | |
EP3052484A4 (en) | Sulfonylindole derivatives and method for preparing the same | |
EP3001881A4 (en) | PHOTOVOLTAIC DEVICES AND METHODS OF MAKING THE SAME | |
PT2980096T (pt) | Métodos de preparação de 2,3,5 tri-hidroxi-androst-6-ona e utilização do mesmo |